You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 1101 to 1125 of about 5880
Next 25
03/14/2019
Optune Open Houses
03/13/2019
Newly Diagnosed Glioblastoma: A Review on Clinical Management
03/12/2019
A randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma
Northwell neurosurgeons remove “glowing” brain tumor using breakthrough technology in Long Island first
xCures to Implement an Intermediate Size Expanded Access Protocol for ONC201 in H3 K27M-mutant Gliomas
03/10/2019
Triple-drug Therapy With Bevacizumab, Irinotecan, and Temozolomide Plus Tumor Treating Fields for Recurrent Glioblastoma: A Retrospective Study.
03/09/2019
Update on Medicare CAC meeting
National Walk To End Brain Tumors
Optune Open House
03/05/2019
Brain tumor advocacy alert - we need you to watch this video Wednesday Morning 3/6/19 at 9am Eastern Time!
03/02/2019
Parkinson’s and cancer hope from implant drilled into skull to deliver drugs with pinpoint precision
The sneaky way estrogen drives brain metastasis in non-estrogen-dependent breast cancers
02/27/2019
Medicare meeting about Optune! Tune in this Wednesday March 6, 2019
02/23/2019
Improved survival of glioblastoma patients treated at academic and high-volume facilities: a hospital-based study from the National Cancer Database.
02/22/2019
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial
Tocagen is looking for patients with high grade glioma (glioblastoma or anaplastic astrocytoma) and caregivers to participate in an advisory board event in San Diego from March 20-21st.
02/21/2019
Major Advocacy Issure: Optune
Malaria drug successfully treats 26-year-old brain cancer patient
02/17/2019
why some brain tumors respond to immunotherapy
Confirmation of high therapeutic effect in doctor-led clinical trials of viral therapy for brain tumor - Application for approval for the manufacture and marketing of the first cancer treatment viral drug in Japan -
02/15/2019
Statins, NSAIDS Have No Apparent Survival Benefit for Grade IV Glioma
02/14/2019
Contractor Advisory Committee (CAC) Meeting Information - Tumor Treatment Field Therapy (L34823)
University of Minnesota First in U.S. to Offer New Targeted Therapy for Recurrent Brain Tumors
02/13/2019
Aspirin inhibits cancer stem cells properties and growth of glioblastoma multiforme through Rb1 pathway modulation
Progesterone is more effective than dexamethasone in prolonging overall survival and preserving neurologic functions in experimental animals with orthotopic glioblastoma allografts.